PageGroup plc
MPGPY News Today: Stay Updated with the Latest PageGroup plc News in Real Time
Find MPGPY news now at Meyka AI. Stay informed with the latest PageGroup plc stocks updates, including price news, market analysis, and expert insights.

FTSE 100 Energy Stocks Surge as BP plc Leads Market Momentum
The FTSE 100 has recently gained strong attention as energy stocks push the index higher. We are seeing a clear rally in the energy sector, driven by rising oil prices and strong earnings expectations. At the center of this movement is the FTSE 100, where energy companies are playing a major role in lifting overall…

LLDTF Lloyds Banking Group Earnings Preview April 29
Lloyds Banking Group earnings preview for April 29, 2026. EPS estimate $0.0283, revenue estimate $6.50B. What to watch.

GSK plc (GSK) Earnings Preview April 29, 2026
GSK earnings preview for April 29, 2026. Analysts expect $1.17 EPS and $10.23B revenue. Review estimates and historical performance.

AZN AstraZeneca Earnings Preview April 29, 2026
AstraZeneca earnings preview: Analysts expect $2.52 EPS and $14.92B revenue on April 29. Meyka AI rates AZN with B+ grade.

SLNA stock plunges 20% in pre-market trading on Apr 28
SLNA stock drops 20.2% to $0.03 in pre-market trading. Selina Hospitality faces negative earnings and weak cash flow metrics.

ZEG.DE AstraZeneca Earnings Preview April 29, 2026
AstraZeneca earnings preview: $2.13 EPS and $12.73B revenue expected April 29. Analyst estimates and what to watch.

CRWKF Initiated Neutral at Exane BNP Paribas April 2026
Exane BNP Paribas initiates Cranswick (CRWKF) with Neutral rating on April 27, 2026. Stock trades at $66.55.

GGGSF Downgraded to Underperform by BNP Paribas April 2026
Exane BNP Paribas initiated GGGSF with Underperform rating on April 27, 2026, citing concerns about the bakery retailer’s growth trajectory.

GENSF Initiated Neutral at Exane BNP Paribas April 2026
Exane BNP Paribas initiated Genus plc (GENSF) with a Neutral rating on April 27, 2026, citing balanced outlook for the animal genetics company.